A detailed history of Black Rock Inc. transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,082,031 shares of GTHX stock, worth $22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,082,031
Previous 672,027 358.62%
Holding current value
$22 Million
Previous $2.9 Million 142.06%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.2 - $4.98 $5.3 Million - $12 Million
2,410,004 Added 358.62%
3,082,031 $7.03 Million
Q1 2024

May 10, 2024

SELL
$2.1 - $4.83 $18,137 - $41,716
-8,637 Reduced 1.27%
672,027 $2.9 Million
Q4 2023

Feb 13, 2024

SELL
$1.12 - $3.73 $492,400 - $1.64 Million
-439,643 Reduced 39.24%
680,664 $2.08 Million
Q3 2023

Nov 13, 2023

SELL
$1.22 - $2.67 $79,712 - $174,452
-65,338 Reduced 5.51%
1,120,307 $1.61 Million
Q2 2023

Aug 11, 2023

SELL
$2.46 - $3.14 $495,082 - $631,934
-201,253 Reduced 14.51%
1,185,645 $2.95 Million
Q1 2023

May 12, 2023

SELL
$2.57 - $8.16 $271,420 - $861,785
-105,611 Reduced 7.08%
1,386,898 $3.72 Million
Q4 2022

Feb 13, 2023

SELL
$5.19 - $13.5 $140,898 - $366,498
-27,148 Reduced 1.79%
1,492,509 $8.1 Million
Q3 2022

Nov 14, 2022

BUY
$5.17 - $16.99 $777,443 - $2.55 Million
150,376 Added 10.98%
1,519,657 $19 Million
Q2 2022

Aug 12, 2022

SELL
$4.04 - $8.51 $7.8 Million - $16.4 Million
-1,930,568 Reduced 58.5%
1,369,281 $6.76 Million
Q1 2022

May 12, 2022

SELL
$7.6 - $11.02 $78,758 - $114,200
-10,363 Reduced 0.31%
3,299,849 $25.1 Million
Q4 2021

Feb 10, 2022

BUY
$10.16 - $16.17 $692,170 - $1.1 Million
68,127 Added 2.1%
3,310,212 $33.8 Million
Q3 2021

Nov 09, 2021

BUY
$13.16 - $22.47 $162,118 - $276,807
12,319 Added 0.38%
3,242,085 $43.5 Million
Q2 2021

Aug 11, 2021

BUY
$19.57 - $26.32 $63.2 Million - $85 Million
3,229,766 New
3,229,766 $70.9 Million

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.